Home > Insider Trading > Filing (0001225208-17-005102)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1437590	Mikael Dolsten	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	President R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-02-27	31,800	$0.00	172,115	No	4	A	Direct
Common Stock	Disposition	2017-02-27	6,655	$34.25	165,460	No	4	S	Direct
Common Stock	Disposition	2017-02-27	16,400	$34.28	149,060	No	4	F	Direct
Common Stock	Disposition	2017-02-27	16,581	$34.28	132,479	No	4	F	Direct
Common Stock	Disposition	2017-02-27	24,668	$34.27	107,811	No	4	S	Direct
Common Stock	Disposition	2017-02-27	27,523	$34.26	80,288	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,516	Indirect	By Rule 16b-3 Plan

Footnotes

The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).